| 000 | 00918 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518030332.0 | ||
| 264 | 0 | _c20200507 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1365-2796 | ||
| 024 | 7 |
_a10.1111/joim.12893 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTobiasson, M | |
| 245 | 0 | 0 |
_aTreatment of myelodysplastic syndrome in the era of next-generation sequencing. _h[electronic resource] |
| 260 |
_bJournal of internal medicine _c07 2019 |
||
| 300 |
_a41-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdrug therapy |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 700 | 1 | _aKittang, A O | |
| 773 | 0 |
_tJournal of internal medicine _gvol. 286 _gno. 1 _gp. 41-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/joim.12893 _zAvailable from publisher's website |
| 999 |
_c29475798 _d29475798 |
||